Table 1.

Availability of clinical genomic sequencing tests globally: whole-exome sequencing, non-invasive prenatal testing and tumour sequencing

Test	North America	Central/ South America	Europe	Middle east	Asia/Oceania	Other countries
Whole-exome sequencing	USA Canada Mexico	Brazil Argentina Colombia Argentina Peru	UK, Germany Belgium, Denmark, Netherlands, Sweden, Italy, Spain, Ireland, Estonia, Finland, France	Saudi Arabia Qatar Turkey Israel	Australia China Japan South Korea Taiwan	South Africa
Non-invasive prenatal testing	USA Canada Mexico	Brazil Argentina Colombia Argentina Peru	UK, France, Belgium, Denmark, Netherlands, Switzerland, Czech Republic, Sweden, Germany, Italy, Spain Ireland	Saudi Arabia Qatar Turkey Israel	Australia China Japan South Korea Taiwan	South Africa
Tumour sequencing	USA Canada Mexico	Brazil Argentina Chile Colombia Venezuela Peru	UK, Belgium, Czech Republic, Netherlands, Sweden, Norway, France, Germany, Spain, Italy, Estonia, Finland, Ireland	Saudi Arabia Qatar Turkey Israel	Australia China Japan South Korea Taiwan	South Africa Egypt

Availability is based on the best available information obtained using a range of sources, including the grey literature and interviews with experts (personal communications, Veronique Forest, Marius Van Den Berg, 10/20/20).³⁰ However, this table is illustrative and thus may not include all relevant countries. Also, we could not assess the availability of whole genome (vs exome) independently but many countries have both tests available.